Delivery of drugs to the eye by topical application

Progress in Retinal and Eye Research

Volumn 15, Issue 2, 1996, Pages 583-620

  Sasaki, Hitoshi ^a   Yamamura, Kenzo ^b   Nishida, Koyo ^b   Nakamura, Junzo ^b   Ichikawa, Masataka ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AGENTS ACTING ON THE EYE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; COLLAGEN; CYCLODEXTRIN; CYCLOSPORIN; CYTOKINE; DEXAMETHASONE; DIPIVEFRINE; DRUG VEHICLE; GROWTH FACTOR; INTERFERON; LAUROCAPRAM; LIPOSOME; NANOPARTICLE; PILOCARPINE; PRODRUG; PROSTAGLANDIN DERIVATIVE; STEROID; UNINDEXED DRUG;

ANTERIOR EYE CHAMBER; CONTACT LENS; CORNEA PERMEABILITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DESIGN; DRUG DISPOSITION; DRUG FORMULATION; DRUG IMPLANT; DRUG PENETRATION; EMULSION; GLAUCOMA; HUMAN; IONTOPHORESIS; LIPOPHILICITY; MEMBRANE PERMEABILITY; NONHUMAN; OINTMENT; PHARMACEUTICS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SUSPENSION; TEAR FLOW; TOPICAL DRUG ADMINISTRATION;

EID: 0029757658     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/1350-9462(96)00014-6     Document Type: Review

References (174)

1. Abrahamsson, T., Boström, S., Bräutigam, J., Lagerström, P. O., Regårdh, C. G. and Vauqelin, G. (1988) Binding of the β-blockers timolol and H 216/44 to ocular melanin. Expl Eye Res. 47: 565-577.
2. Ahmed, I. and Patton, T. F. (1987) Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption. Int. J. Pharm. 38: 9-21.
3. Ahmed, I., Francoeur, M. L., Thombre, A. G. and Patton, T. F. (1989) The kinetics of timolol in the rabbit lens: implications for ocular drug delivery. Pharm. Res. 6: 772-778.
4. Ashton, P., Podder, S. K. and Lee, V. H. L. (1991) Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration. Pharm. Res. 8: 1166-1174.
5. Barber, R. F. and Shek, P. N. (1990) Tear-induced release of liposome-entrapped agents. Int. J. Pharm. 60: 219-227.
6. Barza, M., Peckman, C. and Baum, J. (1986) Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit. Ophthalmology 93: 133-139.
7. Barza, M., Stuart, M. and Szoka, F. Jr. (1987) Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. Invest. Ophthalmol. Vis. Sci. 28: 893-900.
8. Bodor, N., ElKoussi, A., Kano, M. and Nakamura, T. (1988) Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for β-adrenergic blocking agents. J. Med. Chem. 31: 100-106.
9. Bodor, N. and Elkoussi, A. (1991) Improved delivery through biological membranes. LVI. Pharmacological evaluation of alprenoxime - a new potential antiglaucoma agent. Pharm. Res. 8: 1389-1395.
10. Bundgaard, H., Falch, E., Larsen, C., Mosher, G. L. and Mikkelson, T. J. (1985) Pilocarpic acid esters as novel sequentially labile pilocarpine prodrugs for improved ocular delivery. J. Med. Chem. 28: 979-981.
11. Burstein, N. L. (1984) Preservative alteration of corneal permeability in humans and rabbits. Invest. Ophthalmol. Vis. Sci. 25: 1453-1457.
12. Burton, G. D. and Hill, R. M. (1981) Aerobic responses of the cornea to ophthalmic preservatives, measured in vivo. Invest. Ophthalmol. Vis. Sci. 21: 842-845.
13. 2α and its isopropyl ester in vitro. Int. J. Pharm. 37: 27-32.
14. Camber, O. and Edman, P. (1987b) Influence of some preservatives on the corneal permeability of pilocarpine and dexamethasone in vitro Int. J. Pharm. 39: 229-234.
15. Chang, S.-C., Bundgaard, H., Buur, A. and Lee, V. H. L. (1987) Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest. Ophthalmol. Vis. Sci. 28: 487-491.
16. Chang, S.-C., Bundgaard, H., Buur, A. and Lee, V. H. L. (1988) Low dose O-butyryl timolol improves the therapeutic index of timolol in the pigmented rabbit. Invest. Ophthalmol. Vis. Sci. 29: 626-629.
17. 2α. Br. J. Ophthalmol. 78: 560-567.
18. 3H hydrochloride. J. Pharmacokinet. Biopharm. 14: 175-211.
19. Chien, D.-S., Bundgaard, H. and Lee, V. H. L. (1988) Influence of corneal epithelial integrity on the penetration of timolol prodrugs. J. Ocul. Pharmacol. 4: 137-146.
20. Chien, D.-S. and Schoenwald, R. D. (1990) Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes. Pharm. Res. 7: 476-483.
21. Chien, D.-S., Sasaki, H., Bundgaard, H., Buur, A. and Lee, V. H. L. (1991) Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit. Pharm. Res. 8: 728-733.
22. Chiou, G. C. Y. (1991) Systemic delivery of polypeptide drugs through ocular route. Ann. Rev. Pharmacol. Toxicol. 31: 457-467.
23. Chrai, S. S., Patton, T. F., Mehta, A. and Robinson, J. R. (1973) Lacrimal and instilled fluid dynamics in rabbit eyes. J. Pharm. Sci. 62: 1112-1121.
24. Chrai, S. S., Makoid, M. C., Eriksen, S. P. and Robinson, J. R. (1974) Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J. Pharm. Sci. 63: 333-338.
25. Chrai, S. S. and Robinson, J. R. (1974) Ocular evaluation of methylcellulose vehicle in albino rabbits. J. Pharm. Sci. 63: 1218-1223.
26. Conrad, J. M. and Robinson, J. R. (1977) Aqueous chamber drug distribution volume measurement in rabbits. J. Pharm. Sci. 66: 219-224.
27. Davies, N. M., Farr, S. J., Hadgraft, J. and Kellaway, I. W. (1991) Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions. Pharm. Res. 8: 1039-1043.
28. Davies, N. M., Farr, S. J., Hadgraft, J. and Kellaway, I. W. (1992) Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles. Pharm. Res. 9: 1137-1144.
29. 14C]-cicrylate nanoparticles in healthy and chronically inflamed rabbit eyes. Int. J. Pharm. 54: 149-153.
30. Doane, M. G., Jensen, A. D. and Dohlman, C. H. (1978) Penetration routes of topically applied eye medications. Am. J. Ophthalmol. 85: 383-386.
31. Dumortier, G., Zuber, M., Chast, F., Sandouk, P. and Chaumeil, J. C. (1990) Systemic absorption of morphine after ocular administration: evaluation of morphine salt insert in vitro and in vivo. Int. J. Pharm. 59: 1-7.
32. Durrani, A. M., Davies, N. M., Thomas, M. and Kellaway, I. W. (1992) Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system. Int. J. Pharm. 88: 409-415.
33. Durrani, A. M., Farr, S. J. and Kellaway, I. W. (1995) Precorneal clearance of mucoadhesive microspheres from the rabbit eye. J. Pharm. Pharmacol. 47: 581-584.
34. Eller, M. G., Schoenwald, R. D., Dixson, J. A., Segarra, T. and Barfknecht, C. F. (1985a) Topical carbonic anhydrase inhibitors III: optimization model for corneal penetration of ethoxzolamide analogues. J. Pharm. Sci. 74: 155-160.
35. Eller, M. G., Schoenwald, R. D. Dixson, J. A., Segarra, T. and Barfknecht, C. F. (1985b) Topical carbonic anhydrase inhibitors IV: relationship between excised corneal permeability and pharmacokinetic factors. J. Pharm. Sci. 74: 525-529.
36. Finne, U., Väisänen, V. and Urtti. A. (1990) Modification of ocular and systemic absorption of timolol from ocular inserts by a buffering agent and a vasoconstrictor. Int. J. Pharm. 65: 19-27.
37. Finne. U., Salivirta, J. and Urtti, A. (1991) Sodium acetate improves the ocular/systemic absorption ratio of timolol applied ocularly in monoisopropyl PVM-MA matrices. Int. J. Pharm. 75: R1-R4.
38. Finne, U. and Urtti, A. (1992) Pharmacokinetic simulation reveals in vivo deviations from in vitro release of timolol from polymer matrices. Int. J. Pharm. 84: 217-222.
39. Fitzgerald, P., Hadgraft, J. and Wilson, C. G. (1987) A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit. J. Pharm. Pharmacol. 39: 487-490.
40. Fraunfelder, F. T., Shell, J. W. and Herbst, S. F. (1976) Effect of pilocarpine ocular therapeutic systems on diurnal control of intraocular pressure. Annals Ophthalmol. Sept: 1031-1039.
41. George, F. J. and Hanna, C. (1977) Ocular penetration of chloramphenicol. Effects of route of administration. Archs Ophthalmol. 95: 879-882.
42. Grass, G. M.. Wood, R. W. and Robinson, J. R. (1985) Effects of calcium chelating agents on corneal permeability. Invest. Ophthalmol. Vis. Sci. 26: 110-113.
43. Grass, G. M. and Robinson, J. R. (1988) Mechanisms of corneal drug penetration I: in vivo and in vitro kinetics. J. Pharm. Sci. 77: 3-14.
44. Grass, G. M. and Lee, V. H. L. (1993) A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs. Invest. Ophthalmol. Vis. Sci. 34: 2251-2259.
45. Green, K. and Tønjum. A. (1971) Influence of various agents on corneal permeability. Am. J. Ophthalmol. 72: 897-905.
46. Green, K. and Tønjum, A. M. (1975) The effect of benzalkonium chloride on the electropotential of the rabbit cornea. Acta Ophthalmol. 53: 348-357.
47. Green, K. (1993) The effects of preservatives on corneal permeability of drugs. In: Biopharmaceutics of Ocular Drug Delivery (P. Edman, ed.), pp. 43-59. CRC Press, Boca Raton.
48. Grossman, R. E., Chu, D. F. and Lee, D. A. (1990) Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis. Invest. Ophthalmol. Vis. Sci. 31: 909-916.
49. Gunning, F. P., Greve, E. L., Bron, A. M., Bosc, J. M., Royer, J. G., George, J. L., Lesure, P. and Sirbat, D. (1993) Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study. Graefes Archs clin. expl Ophthalmol. 231: 384-388.
50. Harper, C. A. 3rd., Khoobehi, B., Peyman, G. A., Gebhardt, B. M. and Dunlap, W. A. (1993-94) Bioavailability of microsphere-entrapped cyclosporine A in the cornea and aqueous of rabbits. Int. Ophthalmol. 17: 337-340.
51. Harris, D., Liaw, J.-H. and Robinson, J. R. (1992) Ocular delivery of peptide and protein drugs. Adv. Drug Del. Rev. 8: 331-339.
52. Hayakawa, E., Chien, D.-S., Inagaki, K., Yamamoto, A., Wang, W. and Lee, V. H. L. (1992) Conjunctival penetration of insulin and peptide drugs in the albino rabbit. Pharm. Res. 9: 769-775.
53. Himmelstein, K. J., Guvenir, I. and Patton, T. F. (1978) Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye. J. Pharm. Sci. 67: 603-606.
54. Hochman, J. and Artursson, P. (1994) Mechanisms of absorption enhancement and tight junction regulation. J. Contr. Rel. 29: 253-267.
55. Hou, W.-M., Miyazaki, S. and Takada, M. (1985) Controlled release of pilocarpine hydrochloride from ethylene-vinyl alcohol copolymer matrices. Chem. Pharm. Bull. 33: 1242-1248.
56. Huang, H.-S., Schoenwald, R. D. and Lach, J. L. (1983) Corneal penetration behavior of β-blocking agents II: assessment of barrier contributions. J. Pharm. Sci. 72: 1272-1279.
57. Huang, A. J. W., Tseng, S. C. G. and Kenyon, K. R. (1989) Paracellular permeability of corneal and conjunctival epithelia. Invest. Ophthalmol. Vis. Sci. 30: 684-689.
58. Hui, H.-W. and Robinson, J. R. (1986) Effect of particle dissolution rate on ocular drug bioavailability. J. Pharm. Sci. 75: 280-287.
59. Huupponen, R., Kaila, T., Saettone. M. F., Monti, D., Ilsalo, E., Salminen, L. and Oksala, O. (1992) The effect of some macromolecular ionic complexes on the pharmacokinetics and -dynamics of ocular cyclopentolate in rabbits. J. Ocul. Pharmacol. 8: 59-67.
60. Hwang, D. G., Stern, W. H., Hwang, P. H. and MacGowan-Smith, L. A. (1989) Collagen shield enhancement of topical dexamethasone penetration. Archs Ophthalmol. 107: 1375-1380.
61. Ibrahim, H., Bindschaedler, C., Doelker, E., Buri, P. and Gurny, R. (1991) Concept and development of ophthalmic pseudo-latexes triggered by pH. Int. J. Pharm. 77: 211-219.
62. Ismail, I. M., Chen, C.-C., Richman, J. B., Andersen, J. S. and Tand-Liu, D. D.-S. (1992) Comparison of Azone and hexamethylene lauramide in toxicologic effects and penetration enhancement of cimetidine in rabbit eyes. Pharm. Res. 9: 817-821.
63. Jani, R., Gan, O.. Ali, Y., Rodstrom, R. and Hancock, S. (1994) Ion exchange resins for ophthalmic delivery. J. Ocul. Pharmacol. 10: 57-67.
64. Jones, R. F. and Maurice, D. M. (1966) New methods of measuring the rate of aqueous flow in man with fluorescent. Expl Eye Res. 5: 208-220.
65. Kato, A. and Iwata, S. (1988) Studies on improved corneal permeability to bunazosin. J. Pharmacobio-Dyn. 11: 330-334.
66. Keister, J. C., Cooper, E. R., Missel, P. J., Lang, J. C. and Hager, D. F. (1991) Limits on optimizing ocular drug delivery. J. Pharm. Sci. 80: 50-53.
67. Khoobehi, B., Peyman. G. A., Niesman, M. R. and Oncel, M. (1989) Hyperthermia and temperature-sensitive liposomes: selective delivery of drugs into the eye. Japan. J. Ophthalmol. 33: 405-412.
68. Kimura, H., Ogura, Y., Hashizoe, M., Nishiwaki, H., Honda, Y. and Ikada, Y. (1994) A new vitreal drug delivery system using an implantable biodegradable polymeric device. Invest. Ophthalmol. Vis. Sci. 35: 2815-2819.
69. Klyce, S. D. and Crosson, C. E. (1985) Transport processes across the rabbit corneal epithelium: a review. Curr. Eye Res. 4: 323-331.
70. Larsen, J. D., Bundgaard, H. and Lee, V. H. L. (1988) Prodrug forms for the sulfonamide group. II. Water-soluble amino acid derivatives of N-methylsulfonamides as possible prodrugs. Int. J. Pharma. 47: 103-110.
71. Lee. V. H. L. and Robinson, J. R. (1979) Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J. Pharm. Sci. 68: 673-684.
72. Lee, V. H. L (1983) Esterase activities in adult rabbit eyes. J. Pharm. Sci. 72: 239-244.
73. Lee, V. H. L., Takemoto, K. A. and Iimoto, D. S. (1984) Precorneal factors influencing the ocular distribution of topically applied liposomal inulin. Curr. Eye Res. 3: 585-591.
74. Lee, V. H. L. and Robinson, J. R. (1986) Topical ocular drug delivery: recent developments and future challenges. J. Ocul. Pharmacol. 2: 67-108.
75. Lee, V. H. L., Chien, D.-S. and Sasaki, H. (1988) Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit. J. Pharmacol. Expl Ther. 246: 871-878.
76. Lee, V. H. L. (1993) Improved ocular drug delivery by use of chemical modification (prodrugs). In: Biopharmaceutics of Ocular Drug Delivery (P. Edman, ed.), pp. 121-143. CRC Press, Boca Raton.
77. Lee, V. H. L., Li, S. Y.. Sasaki, H., Saettone, M. F. and Chetoni, P. (1994) Influence of drug release rate on systemic timolol absorption from polymeric ocular inserts in the pigmented rabbit. J. Ocul. Pharmacol. 10: 421-429.
78. Leung, S.-H. S. and Robinson, J. R. (1988) The contribution of anionic polymer structural features to mucoadhesion. J. Contr. Rel. 5: 223-231.
79. Liaw, J., Rojanasakul, Y. and Robinson, J. R. (1992) The effect of drug charge type and charge density on corneal transport. Int. J. Pharm. 88: 111-124.
80. Loftsson, T., Frithriksdóttir, H., Stefánsson, E., Thórisdóttir, S., Guthmundsson, Ö. and Sigthórsson, T. (1994) Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J. Pharm. Pharmacol. 46: 503-504.
81. Losa. C., Marchal-Heussler, L., Orallo, F.. Jato, J. L. V. and Alonso, M. J. (1993) Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm. Res. 10: 80-87.
82. Macoul, K. L. and Pavan-Langston, D. (1975) Pilocarpine ocusert system for sustained control of ocular hypertension. Archs Ophthalmol. 93: 587-590.
83. Makoid, M. C. and Robinson, J. R. (1979) Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye. J. Pharm. Sci. 68: 435-443.
84. Marchal-Heussler, L., Sirbat, D.. Hoffman, M. and Maincent, P. (1993) Poly(c-caprolactone) nanocapsules in carteolol ophthalmic delivery. Pharm. Res. 10: 386-390.
85. Marsh, R. J. and Maurice, D. M. (1971) The influence of non-ionic detergents and other surfactants on human corneal permeability. Expl Eye Res. 11: 43-48.
86. Maurice, D. M. and Srinivas, S. P. (1992) Use of fluorometry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle: comparison with scintigraphy. J. Pharm. Sci. 81: 615-619.
87. McCarey, B. E., Edelhauser, H. F. and Van Horn, D. L. (1973) Functional and structural changes in the corneal endothelium during in vitro perfusion. Invest. Ophthalmol. Vis. Sci. 12: 410-417.
88. Megaw, J. M. and Lerman, S. (1987) Application of miniosmotic pumps for liposomal drug delivery to the ocular lens. Invest. Ophthalmol. Vis. Sci. 28: 1429-1433.
89. Meisner, D., Pringle, J. and Mezei, M. (1989) Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine. Int. J. Pharm. 55: 105-113.
90. Mikkelson, T. J., Chrai, S. S. and Robinson, J. R. (1973) Altered bioavailability of drugs in the eye due to drug-protein interaction. J. Pharm. Sci. 62: 1648-1653.
91. Miller, S. C., Himmelstein, K. J. and Patton, T. F. (1981) A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits. J. Pharmacokinet. Biopharm. 9: 653-677.
92. Mishima, S., Gasset, A., Klyce, S. D. Jr. and Baum, J. L. (1966) Determination of tear volume and tear flow. Invest. Ophthalmol. 5: 264-276.
93. Mishima, S. (1981) Clinical pharmacokinetics of the eye. Invest. Ophthalmol. Vis. Sci. 21: 504-541.
94. Mitra, A. K. and Mikkelson, T. J. (1988) Mechanism of transcorneal permeation of pilocarpine. J. Pharm. Sci. 77: 771-775.
95. Morimoto, K., Nakai, T. and Morisaka, K. (1987) Evaluation of permeability enhancement of hydrophilic compounds and macromolecular compounds by bile salts through rabbit corneas in-vitro. J. Pharm. Pharmacol. 39: 124-126.
96. Muchtar, S., Almog, S., Torracca, M. T., Saettone, M. F. and Benita, S. (1992) A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits. Ophthalmic Res. 24: 142-149.
97. Neubert, R. (1989) Ion pair transport across membranes. Pharm. Res. 6: 743-747.
98. Newton, C., Gebhardt, B. M. and Kaufman, H. E. (1988) Topically applied cyclosporine in Azone prolongs corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 29: 208-215.
99. Norley. S. G., Sendele, D., Huang. L. and Rouse, B. T. (1987) Inhibition of herpes simplex virus replication in the mouse cornea by drug containing immunoliposomes. Invest. Ophthalmol. Vis. Sci. 28: 591-595.
100. Norn, M. (1985) The effects of drugs on tear flow. Trans. Ophthalmol. Soc. U.K. 104: 410-414.
101. Novack, G. D. (1987) Ophthalmic beta-blockers since timolol. Surv. Ophthalmol. 31: 307-327.
102. Ohdo, S., Zhu, J. and Lee, V. H. L. (1992) Light-dark variations in ocular timolol concentrations following topical solution instillation in the pigmented rabbit. Life Sci. 51: 2025-2031.
103. Ohtori, A. and Tojo, K. (1994) In vivo/in vitro correlation of intravitreal delivery of drugs with the help of computer simulation. Biol. Pharm. Bull. 17: 283-290.
104. Park, H. and Robinson, J. R. (1987) Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm. Res. 4: 457-464.
105. Patton, T. F. and Robinson, J. R. (1975) Ocular evaluation of polyvinyl alcohol vehicle in rabbits. J. Pharm. Sci. 64: 1312-1316.
106. Patton, T. F. and Robinson, J. R. (1976) Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. J. Pharm. Sci. 65: 1295-1301.
107. Patton, T. F. (1977) Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume. J. Pharm. Sci. 66: 1058-1059.
108. Pech, B., Chetoni, P., Saettone, M. F., Duval, O. and Benoit, J. P. (1993) Preliminary evaluation of a series of amphiphilic timolol prodrugs: possible evidence for transscleral absorption. J. Ocul. Pharmacol. 9: 141-150.
109. Pepose, J. S. and Leib, D. A. (1994) Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases. Invest. Ophthalmol. Vis. Sci. 35: 2662-2666.
110. Pfister, R. R. and Burstein, N. (1976) The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study. Invest. Ophthalmol. 15: 246-259.
111. Pleyer, U., Lutz, S., Jusko, W. J., Nguyen, K., Narawane, M., Rückert, D., Mondino, B. J. and Lee, V. H. L. (1993) Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 34: 2737-2742.
112. Quigley, H. A., Pollack, I. P. and Harbin, T. S. Jr. (1975) Pilocarpine ocuserts. Long-term clinical trials and selected pharmacodynamics. Archs Ophthalmol. 93: 771-775.
113. Raviola, G. (1977) The structural basis of the blood-ocular barriers. Expl Eye Res. 25: 27-63.
114. Reer, O., Bock, T. K. and Müller, B. W. (1994) In vitro corneal permeability of diclofenac sodium in formulations containing cyclodextrins compared to the commercial product Voltaren ophtha. J. Pharm. Sci. 83: 1345-1349.
115. Reidy, J. J., Gebhardt, B. M. and Kaufman, H. E. (1990) The collagen shield. A new vehicle for delivery of cyclosporin A to the eye. Cornea 9: 196-199.
116. Richman, J. B. and Tang-Liu, D. D.-S. (1990) A corneal perfusion device for estimating ocular bioavailability in vitro. J. Pharm. Sci. 79: 153-157.
117. Ritger, P. L. and Peppas, N. A. (1987) A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Contr. Rel. 5: 23-36.
118. Rojanasakul, Y. and Robinson, J. R. (1991) The cytoskeleton of the cornea and its role in tight junction permeability. Int. J. Pharm. 68: 135-149.
119. Rojanasakul, Y., Wang, L.-Y., Bhat, M., Glover, D. D., Malanga, C. J. and Ma, J. K. H. (1992) The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm. Res. 9: 1029-1034.
120. Rootman, D. S., Jantzen, J. A., Gonzalez, J. R., Fischer, M. J., Beuerman, R. and Hill, J. M. (1988) Pharmacokinetics and safety of transcorneal iontophoresis of tobramycin in the rabbit. Invest. Ophthalmol. Vis. Sci. 29: 1397-1401.
121. Rootman, D. S., Willoughby, R. P., Bindlish, R., Avaria, M., Basu, P. K. and Krajden, M. (1992) Continuous flow contact lens delivery of gentamicin to rabbit cornea and aqueous humor. J. Ocul. Pharmacol. 8: 317-323.
122. Saettone, M. F., Giannaccini, B., Chetoni, P., Galli, G. and Chiellini, E. (1984) Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpine. J. Pharm. Pharmacol. 36: 229-234.
123. Saettone, M. F., Chetoni, P., Torracca, M. T., Burgalassi, S. and Giannaccini, B. (1989) Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int. J. Pharm. 51: 203-212.
124. Saettone, M. F., Giannaccini, B., Chetoni, P., Torracca, M. T. and Monti, D. (1991) Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine. Int. J. Pharm. 72: 131-139.
125. Saettone, M. F., Torracca, M. T., Pagano, A., Giannaccini, B., Rodriguez, L. and Cini, M. (1992) Controlled release of pilocarpine from coated polymeric ophthalmic inserts prepared by extrusion. Int. J. Pharm. 86: 159-166.
126. Saettone, M. F. (1993) Solid polymeric inserts/disks as drug delivery devices. In: Biopharmaceutics of Ocular Drug Delivery (P. Edman, ed.), pp. 61-79. CRC Press, Boca Raton.
127. Safwat, S. M., Kassem, M. A., Attia, M. A. and El-Mahdy, M. (1994) The formulation-performance relationship of multiple emulsions and ocular activity. J. Contr. Rel. 32: 259-268.
128. Sasaki, H., Igarashi, Y., Nishida, K. and Nakamura, J. (1993a) Ocular delivery of the β-blocker, tilisolol, through the prodrug approach. Int. J. Pharm. 93: 49-60.
129. Sasaki, H., Tei, C., Nishida, K. and Nakamura, J. (1993b) Drug release from an ophthalmic insert of a beta-blocker as an ocular drug delivery system. J. Contr. Rel. 27: 127-137.
130. Sasaki, H., Tei, C., Yamamura, K., Nishida, K. and Nakamura, J. (1994) Effect of preservatives on systemic delivery of insulin by ocular instillation in rabbits. J. Pharm. Pharmacol. 46: 871-875.
131. Sasaki, H., Igarashi, Y., Nagano, T., Nishida, K. and Nakamura, J. (1995a) Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers. Pharm. Res. 12: 1146-1150.
132. Sasaki, H., Igarashi, Y., Nagano, T., Yamamura, K., Nishida, K. and Nakamura, J. (1995b) Penetration of β-blockers through ocular membranes in albino rabbits. J. Pharm. Pharmacol. 47: 17-21.
133. Sasaki, H., Nagano, T., Yamamura, K., Nishida, K. and Nakamura, J. (1995c) Ophthalmic preservatives as absorption promoters for ocular drug delivery. J. Pharm. Pharmacol. 47: 703-707.
134. Sasaki, H., Yamamura, K., Tei, C., Nishida, K. and Nakamura, J. (1995d) Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug. J. Drug Target. 3: 129-135.
135. Sasamoto, Y., Hirose, S., Ohno, S., Onoé, K. and Matsuda, H. (1991) Topical application of ciclosporin ophthalmic solution containing alpha-cyclodextrin in experimental uveitis. Ophthalmologica 203: 118-125.
136. Schaeffer, H. E. and Krohn, D. L. (1982) Liposomes in topical drug delivery. Invest. Ophthalmol. Vis. Sci. 21: 220-227.
137. Schoenwald, R. D. and Ward, R. L. (1978) Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients. J. Pharm. Sci. 67: 786-788.
138. Schoenwald, R. D., Ward, R. L., DeSantis, L. M. and Roehrs, R. E. (1978) Influence of high-viscosity vehicles on miotic effect of pilocarpine. J. Pharm. Sci. 67: 1280-1283.
139. Schoenwald, R. D., Folk, J. C., Kumar, V. and Piper, J. G. (1987) In vivo comparison of phenylephrine and phenylephrine oxazolidine instilled in the monkey eye. J. Ocul. Pharmacol. 3: 333-340.
140. Schoenwald, R. D. (1990) Ocular drug delivery, Pharmacokinetic considerations. Clin. Pharmacokinet. 18: 255-269.
141. Shell, J. W. (1982) Pharmacokinetics of topically applied ophthalmic drugs. Surv. Ophthalmol. 26: 207-218.
142. Shell, J. W. (1984) Ophthalmic drug delivery systems. Surv. Ophthalmol. 29: 117-128.
143. Sieg, J. W. and Robinson, J. R. (1975) Vehicle effects on ocular drug bioavailability I: evaluation of fluorometholone. J. Pharm. Sci. 64: 931-936.
144. Sieg, J. W. and Robinson, J. R. (1979) Vehicle effects on ocular drug bioavailability III: shear-facilitated pilocarpine release from ointments. J. Pharm. Sci. 68: 724-728.
145. Sieg, J. W. and Robinson, J. R. (1981) Mechanistic studies on transcorneal permeation of fluorometholone. J. Pharm. Sci. 70: 1026-1029.
146. Smart, J. D., Kellaway, I. W. and Worthington, H. E. C. (1984) An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol. 36: 295-299.
147. Smith, T. J., Pearson, P. A., Blandford, D. L., Brown, J. D., Goins, K. A., Hollins, J. L., Schmeisser, E. T., Glavinos, P., Baldwin, L. B. and Ashton, P. (1992) Intravitreal sustained-release ganciclovir. Archs Ophthalmol. 110: 255-258.
148. Smolen, V. F., Clevenger, J. M., Williams, E. J. and Bergdolt, M. W. (1973) Biophasic availability of ophthalmic carbachol I: mechanisms of cationic polymer- and surfactant-promoted miotic activity. J. Pharm. Sci. 62: 958-961.
149. Snibson, G. R., Greaves, J. L., Soper, N. D. W., Prydal, J. I., Wilson, C. G. and Bron, A. J. (1990) Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy. Eye 4: 594-602.
150. Sørensen, T. and Jensen, F. T. (1979) Tear flow in normal human eyes. Determination by means of radioisotope and gamma camera. Acta Ophthalmol. 57: 564-581.
151. Stjernschantz, J. and Astin, M. (1993) Anatomy and physiology of the eye. Physiological aspects of ocular drug therapy. In: Biopharmaceutics of Ocular Drug Delivery (P. Edman, ed.), pp. 1-25. CRC Press, Boca Raton.
152. Sugaya, M. and Nagataki, S. (1978) Kinetics of topical pilocarpine in the human eye. Japan. J. Ophthalmol. 22: 127-141.
153. Suhonen, P., Järvinen, T., Rytkönen, P., Peura, P. and Urtti, A. (1991) Improved corneal pilocarpine permeability with O,O′-(1,4-Xylylene) bispilocarpic acid ester double prodrugs. Pharm. Res. 8: 1539-1542.
154. Taniguchi, K., Itakura, K., Yamazawa, N., Morisaki, K., Hayashi, S. and Yamada, Y. (1988) Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system. J. Pharmacobio-Dyn. 11: 39-46.
155. Tojo, K. (1989) A model for extraocular fluid dynamics. J. Chem. Engng. Japan 22: 518-521.
156. Urtti, A., Pipkin, J. D., Rork, G. and Repta, A. J. (1990) Controlled drug delivery devices for experimental ocular studies with timolol. 1. In vitro release studies. Int. J. Pharm. 61: 235-240.
157. Urtti, A., Rouhiainen, H., Kaila, T. and Saano, V. (1994) Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans. Pharm. Res. 11: 1278-1282.
158. Urtti, A., Sendo, T., Pipkin, J. D., Rork, G. and Repta, A. J. (1988) Application site dependent ocular absorption of timolol. J. Ocul. Pharmacol. 4: 335-343.
159. Van Buskirk, E. M. (1980) Adverse reactions from timolol administration. Ophthalmology 87: 447-450.
160. Van Ooteghem, M. M. M. (1993) Formulation of ophthalmic solutions and suspensions. Problems and advantages. In: Biopharmaceutics of Ocular Drug Delivery (P. Edman, ed.), pp. 27-42. CRC Press, Boca Raton.
161. Wang, W., Sasaki, H., Chien, D.-S. and Lee, V. H. L. (1991) Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr. Eye Res. 6: 571-579.
162. Watanabe, K., Nakagawa, S. and Nishida, T. (1987) Stimulatory effects of fibronectin and EgF on migration of corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 28: 205-211.
163. Wei, C.-P., Anderson, J. A. and Leopold, I. (1978) Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine. Invest. Ophthalmol. Vis. Sci. 17: 315-321.
164. Whikehart, D. R. and Edelhauser, H. F. (1978) Glutathione in rabbit corneal endothelia: the effects of selected perfusion fluids. Invest. Ophthalmol. Vis. Sci. 17: 455-464.
165. Wilson, C. G., Tomlinson, E., Davis, S. S. and Olejnik, O. (1981) Altered ocular absorption and disposition of sodium cromoglycate upon ion-pair and complex coacervate formation with dodecylbenzyldimethyl-ammonium chloride. J. Pharm. Pharmacol. 31: 749-753.
166. Woltersdorf, O. W. Jr., Schwam, H., Bicking, J. B., Brown, S. L., deSolms, S. J., Fishman, D. R., Graham, S. L., Gautheron, P. D., Hoffman, J. M., Larson, R. D., Lee, W. S., Michelson, S. R., Robb, C. M., Share, N. N., Shepard, K. L., Smith, A. M., Smith, R. L., Sondey, J. M., Strohmaier, K. M., Sugrue, M. F. and Viader, M. P. (1989) Topically active carbonic anhydrase inhibitors. 1. O-Acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide. J. Med. Chem. 32: 2486-2492.
167. Wong, E. K. Jr., Lum, C., To, Y., Pan, C., Kim, L. and Gureghian, E. (1994) Absorption of fluorescein given under the upper lid. Ophthalmology 101: 182-187.
168. 14C]-acrylate nanoparticles in the albino rabbit. Int. J. Pharm. 23: 175-183.
169. Zaki, I., Fitzgerald, P., Hardy, J. G. and Wilson, C. G. (1986) A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man. J. Pharm. Pharmacol. 38: 463-466.
170. Zane, P. A., Brindle, S. D., Gause, D. O., O'Buck, A. J., Raghavan, P. R. and Tripp, S. L. (1990) Physicochemcial factors associated with binding and retention of compounds in ocular melanin of rats: correlations using data from whole-body autoradiography and molecular modeling for multiple linear regression analyses. Pharm. Res. 7: 935-941.
171. Zimmer, A., Mutschler, E., Lambrecht, G., Mayer, D. and Kreuter, J. (1994) Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system. Pharm. Res. 11: 1435-1442.
172. Zimmer, A. and Kreuter, J. (1995) Microspheres and nanoparticles used in ocular delivery systems. Adv. Drug Del. Rev. 16: 61-73.
173. Zimmerman, T. J., Kooner, K. S., Kandarakis, A. S. and Ziegler, L. P. (1984) Improving the therapeutic index of topically applied ocular drugs. Archs Ophthalmol. 102: 551-553.
174. Zimmerman, T. J., Sharir, M., Nardin, G. F. and Fuqua, M. (1992) Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion. Am. J. Ophthalmol. 114: 8-13.